Epigenic Therapeutics raises $20M for gene editing technology - Labiotech.eu

Epigenic Therapeutics, a Chinese biotech gene editing company, has secured $20 million in Series Angel and Pre-A funding.

Epigenic Therapeutics Co., Ltd., a Chinese biotech gene editing company, has secured $20 million in Series Angel and Pre-A funding.  The Series Pre-A funding came from investments by Morningside Ven… [+2631 chars]

full article...